--- title: Top 10 Companies Leading the Global IBS and IBD Therapeutics Market description: the global IBS and IBD therapeutics market is projected to grow from $33.3 billion in 2025 to $52.6 billion by 2030, registering a CAGR of 9.6%. image: https://blog.bccresearch.com/hubfs/Rare%20Disease.jpg --- [![BCC Research Blog](https://blog.bccresearch.com/hs-fs/hubfs/bcc_blog-2022/blogs/BCC_Research_Blog.png?width=188&height=45&name=BCC_Research_Blog.png "BCC Research Blog")](https://www.bccresearch.com/) ** ![Top 10 Companies Leading the Global IBS and IBD Therapeutics Market](https://blog.bccresearch.com/hubfs/Rare%20Disease.jpg "Top 10 Companies Leading the Global IBS and IBD Therapeutics Market") # Top 10 Companies Leading the Global IBS and IBD Therapeutics Market ![](https://blog.bccresearch.com/hubfs/Amrita-Kumari.png) [ Amrita Kumari](https://blog.bccresearch.com/author/amrita-kumari) ![date](https://blog.bccresearch.com/hubfs/bcc_blog-2022/blogs/date.svg) Aug 13, 2025 [Blog](https://blog.bccresearch.com/) ** [biotechnology](https://blog.bccresearch.com/topic/biotechnology) ** Top 10 Companies Leading the Global IBS and IBD Therapeutics Market Digestive health disorders such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) significantly affect the quality of life for millions globally. With rising prevalence, earlier diagnoses, and more targeted treatments, the global therapeutics market for IBS and IBD is gaining rapid momentum. According to BCC Research, the [**global IBS and IBD therapeutics market**](https://www.bccresearch.com/market-research/biotechnology/irritable-bowel-syndrome-and-inflammatory-bowel-disease-treatment-market.html) is projected to grow from **$33.3 billion in 2025** to **$52.6 billion by 2030**, registering a **compound annual growth rate (CAGR) of 9.6%, **innovative biologics, small-molecule therapies, microbiome-based approaches, and a strong clinical pipeline fuel this expansion. From traditional pharmaceutical giants to focused biotech, the following companies are at the forefront of this transformation, delivering better outcomes through personalized care, advanced drug development, and global access strategies. 1. ** **[**AbbVie Inc.**](http://www.abbvie.com) **Headquarters:** Illinois, USA | **Founded:** 2013 **Key Areas:** Biologics for Crohn’s disease, ulcerative colitis, IL-23 pathway inhibitors AbbVie dominates the IBD space with Humira (adalimumab), one of the most successful biologics globally. It has continued this legacy with Skyrizi (risankizumab), an IL-23 inhibitor recently approved for Crohn’s disease. With strategic investments in immunology R&D, AbbVie remains a global leader in chronic inflammatory gastrointestinal diseases. 1. ** **[**Takeda Pharmaceuticals**](http://www.takeda.com) **Headquarters:** Tokyo, Japan | **Founded:** 1781 **Key Areas:** Gut-selective biologics, IBS-D/IBS-C treatment, immunology Takeda plays a dual role in both the IBS and IBD markets. It markets Entyvio (vedolizumab), a gut-selective biologic for ulcerative colitis and Crohn’s, and has a strong presence in IBS therapies. Takeda commands over 30% of the IBS therapeutics market, focusing on cost-effective innovation and global distribution. 1. ** **[**Johnson & Johnson**](http://www.jnj.com)** (Janssen Biotech)** **Headquarters:** New Jersey, USA | **Founded:** 1886 **Key Areas:** Advanced biologics, long-term IBD management Johnson & Johnson Innovative Medicine (formerly the Janssen Pharmaceutical Companies) offers diverse portfolios spanning multiple therapeutic areas: Oncology, Immunology, Neuroscience, Cardiovascular, Pulmonary Hypertension, and Retina. It is a leading provider of gastroenterology drugs, including IBD therapies. The company markets its products in more than 175 countries. 1. ** **[**Pfizer Inc.**](http://www.pfizer.com) **Headquarters:** New York, USA | **Founded:** 1849 **Key Areas:** JAK inhibitors, small molecule immunomodulators, inflammation Pfizer is expanding its IBD offerings with tofacitinib (Xeljanz), a JAK inhibitor approved for ulcerative colitis. The company is also exploring filgotinib through a strategic partnership, solidifying its position in small-molecule therapies for gastrointestinal inflammation. 1. ** **[**Bristol Myers Squibb**](http://www.bms.com)** (BMS)** **Headquarters:** New York, USA | **Founded:** 1887 **Key Areas**: Immuno-oncology, protein degradation, autoimmune diseases Bristol-Myers Squibb Co. is a global biopharmaceutical company focusing on cardiovascular, anti-infective, and anticancer therapies. The company undertakes the discovery, development, licensing, manufacture, marketing, and distribution of biopharmaceuticals and related healthcare products. It also focuses on psychiatric disorders, diabetes, hepatitis B, HIV/AIDS, and rheumatoid arthritis.  1. ** **[**Amgen Inc.**](http://www.amgen.com) **Headquarters:** California, USA | **Founded:** 1980 **Key Areas**: General medicine, inflammation/autoimmune, oncology Amgen offers biosimilars and biologics in the IBD space and is focusing on expanding global access to its therapies. The company is investing in next-gen biologics for Crohn’s and ulcerative colitis, with a strong interest in real-world data to support clinical outcomes. 1. ** **[**Ironwood Pharmaceuticals**](https://ironwoodpharma.com/) **Headquarters:** Massachusetts, USA | **Founded:** 1998 **Key Areas**: Gastrointestinal (GI) health, rare GI diseases, GC-C agonists Ironwood is a biopharmaceutical company focused on gastrointestinal disorders and rare diseases. It has strategic partnerships with many pharmaceutical companies, including AbbVie, AstraZeneca, and Astellas Pharma. Ironwood's strategy involves expanding its GI product pipeline and increasing the global supply of its commercialized products.  1. ** **[**Ardelyx Inc.**](https://ardelyx.com/) **Headquarters:** California, USA | **Founded:** 2007 **Key Areas**: GI & cardiorenal health, first-in-class NHE3 inhibitor, CKDrelated hyperphosphatemia Ardelyx is focused on developing novel therapies for underserved gastrointestinal (GI) and kidney-related (cardiorenal) conditions using its proprietary NHE3 inhibitor, **tenapanor**. It currently markets two products in the U.S.: **IBSRELA **for IBSC and **XPHOZAH** for hyperphosphatemia in CKD on dialysis, all as tenapanor formulations. 1. ** **[**Celltrion**](http://www.celltrion.com) **Headquarters:** Incheon, South Korea | **Founded:** 2002 **Key Areas**: Global distribution of biosimilars; mAb biosimilar therapeutics for autoimmune diseases and oncology. Celltrion Healthcare is the commercial and distribution arm of Celltrion, Inc., responsible for globally marketing and distributing biologics and biosimilars developed in Celltrion’s R&D and manufacturing network. Its products reach over *100 countries* through direct and partner distribution channels across the Americas, Europe, Asia, CIS, and the Middle East, making it Korea’s leading exporter of biosimilars. 1. ** **[**UCB S.A**.](http://www.ucb.com) **Headquarters:** Brussels, Belgium | **Founded:** 1928 **Key Areas**: Neurology (epilepsy, Parkinson’s, myasthenia gravis), immunology (TNF‑α, IL‑17 targets) UCB is a global biopharmaceutical company focused on developing innovative therapies for people living with severe neurological and immunological diseases, particularly epilepsy, Parkinson’s disease, myasthenia gravis, and various autoimmune disorders. ## **Conclusion** The global IBS and IBD therapeutics market is transforming. As the need for personalized, effective, and accessible treatments continues to rise, these companies are leading the charge, blending science, strategy, and innovation. With the market projected to reach **$52.6 billion by 2030**, IBS and IBD therapies are no longer niche specialties. They are central to global efforts to improve digestive health and chronic disease management. ### Stay ahead of industry trends, build your market research strategy and more. ## Recent Posts ![Sweet Intelligence: How AI is Transforming the $180 Billion Confectionery Ingredients Game](https://blog.bccresearch.com/hs-fs/hubfs/AI-Generated%20Media/Images/Modern%20Confectionery%20Lab%20with%20AI%20Tech%20and%20Colorful%20Samples.png?quality=low&width=150&height=100&name=Modern%20Confectionery%20Lab%20with%20AI%20Tech%20and%20Colorful%20Samples.png) #### [Sweet Intelligence: How AI is Transforming the $180 Billion Confectionery Ingredients Game 1 min. read | Featured, food-and-beverage, artificial intelligence technology](https://blog.bccresearch.com/how-ai-is-transforming-the-180-billion-confectionery-ingredients-game) ![AI Is Quietly Revolutionizing How We Make the Foam That's Everywhere](https://blog.bccresearch.com/hs-fs/hubfs/AI-Generated%20Media/Images/Foam%20Lab%20with%20Robotic%20Arm%20and%20Data%20Analytics.png?quality=low&width=150&height=100&name=Foam%20Lab%20with%20Robotic%20Arm%20and%20Data%20Analytics.png) #### [AI Is Quietly Revolutionizing How We Make the Foam That's Everywhere 1 min. read | Semiconductor](https://blog.bccresearch.com/ai-is-quietly-revolutionizing-how-we-make-the-foam-thats-everywhere) ![Medical Plastics Meets AI: The Manufacturing Revolution Healthcare Didn't See Coming](https://blog.bccresearch.com/hs-fs/hubfs/AI-Generated%20Media/Images/Futuristic%20Manufacturing%20Facility%20with%20Robotic%20Arm%20and%20Holographic%20Interfaces.png?quality=low&width=150&height=100&name=Futuristic%20Manufacturing%20Facility%20with%20Robotic%20Arm%20and%20Holographic%20Interfaces.png) #### [Medical Plastics Meets AI: The Manufacturing Revolution Healthcare Didn't See Coming 1 min. read | medical devices](https://blog.bccresearch.com/medical-plastics-meets-ai) ![The $1 Million Monthly Problem That AI Is Finally Solving in Clinical Trials](https://blog.bccresearch.com/hs-fs/hubfs/AI-Generated%20Media/Images/AIDriven%20Clinical%20Research%20Hub%20with%20Dynamic%20Data%20Visualization.png?quality=low&width=150&height=100&name=AIDriven%20Clinical%20Research%20Hub%20with%20Dynamic%20Data%20Visualization.png) #### [The $1 Million Monthly Problem That AI Is Finally Solving in Clinical Trials 1 min. read | Featured, healthcare](https://blog.bccresearch.com/the-1-million-monthly-problem-that-ai-is-finally-solving-in-clinical-trials) ![Amrita Kumari](https://blog.bccresearch.com/hubfs/Amrita-Kumari.png) ### Written By Amrita Kumari Amrita Kumari is a Senior Executive Email Marketer at BCC Research, with a bachelor’s degree in computer applications. She specializes in content creation and email marketing. ### Related Content [![Protein Labeling: The $2.8 Billion Market Powering Today's Breakthrough Research](https://blog.bccresearch.com/hs-fs/hubfs/AI-Generated%20Media/Images/Modern%20Lab%20with%20Scientist%20and%20Fluorescent%20Tags.png?quality=low&width=380&height=250&name=Modern%20Lab%20with%20Scientist%20and%20Fluorescent%20Tags.png) ](https://blog.bccresearch.com/protein-labeling-the-2.8-billion-market) [ 1 min. read | ](https://blog.bccresearch.com/protein-labeling-the-2.8-billion-market)[biotechnology](https://blog.bccresearch.com/topic/biotechnology) #### [Protein Labeling: The $2.8 Billion Market Powering Today's Breakthrough Research](https://blog.bccresearch.com/protein-labeling-the-2.8-billion-market) Here's a number that might surprise you: U.S. higher education alone spent $117.... [Read more ![Read More](https://blog.bccresearch.com/hs-fs/hubfs/bcc_blog-2022/blogs/read_more_arrow.png?width=12&height=12&name=read_more_arrow.png) ](https://blog.bccresearch.com/protein-labeling-the-2.8-billion-market) [![DNA Read, Write and Edit: The $67.7 Billion Market That's Rewriting Biology](https://blog.bccresearch.com/hs-fs/hubfs/AI-Generated%20Media/Images/Futuristic%20Lab%20with%20DNA%203D%20Printer%20and%20Scientists.png?quality=low&width=380&height=250&name=Futuristic%20Lab%20with%20DNA%203D%20Printer%20and%20Scientists.png) ](https://blog.bccresearch.com/dna-read-write-and-edit-the-67.7-billion-market-thats-rewriting-biology-1) [ 1 min. read | ](https://blog.bccresearch.com/dna-read-write-and-edit-the-67.7-billion-market-thats-rewriting-biology-1)[biotechnology](https://blog.bccresearch.com/topic/biotechnology) #### [DNA Read, Write and Edit: The $67.7 Billion Market That's Rewriting Biology](https://blog.bccresearch.com/dna-read-write-and-edit-the-67.7-billion-market-thats-rewriting-biology-1) Here's a number that might surprise you: the DNA and RNA synthesis market is exp... [Read more ![Read More](https://blog.bccresearch.com/hs-fs/hubfs/bcc_blog-2022/blogs/read_more_arrow.png?width=12&height=12&name=read_more_arrow.png) ](https://blog.bccresearch.com/dna-read-write-and-edit-the-67.7-billion-market-thats-rewriting-biology-1) [![When Pests Outsmart Crops: How AI is Fighting Back in the $180 Billion GM Foods Battle](https://blog.bccresearch.com/hs-fs/hubfs/AI-Generated%20Media/Images/Smart%20Farming%20Fusion%20with%20Nature%20and%20Tech.png?quality=low&width=380&height=250&name=Smart%20Farming%20Fusion%20with%20Nature%20and%20Tech.png) ](https://blog.bccresearch.com/when-pests-outsmart-crops) [ 1 min. read | ](https://blog.bccresearch.com/when-pests-outsmart-crops)[biotechnology](https://blog.bccresearch.com/topic/biotechnology) #### [When Pests Outsmart Crops: How AI is Fighting Back in the $180 Billion GM Foods Battle](https://blog.bccresearch.com/when-pests-outsmart-crops) Here's a problem most people don't think about: the bugs are winning. Pests and ... [Read more ![Read More](https://blog.bccresearch.com/hs-fs/hubfs/bcc_blog-2022/blogs/read_more_arrow.png?width=12&height=12&name=read_more_arrow.png) ](https://blog.bccresearch.com/when-pests-outsmart-crops) ![Guiding smart decisions every step of the way](https://blog.bccresearch.com/hs-fs/hubfs/Blog_Images/workaholic-hand-typing-keyboard-dark-late-night-with-computer.webp?width=1366&height=378&name=workaholic-hand-typing-keyboard-dark-late-night-with-computer.webp) ## Guiding smart decisions every step of the way We are your trusted research partner, providing actionable insights and custom consulting across life sciences, advanced materials, and technology. Allow BCC Research to nurture your smartest business decisions today, tomorrow, and beyond. [ Contact Us ](https://www.bccresearch.com/aboutus/contactus) BCC Research provides objective, unbiased measurement and assessment of market opportunities with detailed market research reports. Our experienced industry analysts assess growth opportunities, market sizing, technologies, applications, supply chains and companies with the singular goal of helping you make informed business decisions, free of noise and hype. ### Stay Informed #### Contact - [**781-489-7301](tel:7814897301) - [**info@bccresearch.com](mailto:info@bccresearch.com) © 2023 BCC Research [Privacy Policy](http://www.bccresearch.com/privacypolicy) |[Site Map](http://www.bccresearch.com/sitemap) #### Connect With Us [![BCC Research](https://blog.bccresearch.com/hs-fs/hubfs/BCCResearch%20-Feb2017/icon-linkedin-ftr.png?width=36&height=36&name=icon-linkedin-ftr.png) ](http://www.linkedin.com/company/bccresearch) [![BCC Research](https://blog.bccresearch.com/hs-fs/hubfs/BCCResearch%20-Feb2017/icon-email-ftr.png?width=36&height=36&name=icon-email-ftr.png) ](mailto:info@bccresearch.com) [![BCC Research](https://blog.bccresearch.com/hs-fs/hubfs/BCCResearch%20-Feb2017/icon-twitter-ftr.png?width=36&height=36&name=icon-twitter-ftr.png) ](https://twitter.com/bccresearch) [![BCC Research](https://blog.bccresearch.com/hs-fs/hubfs/bcc_blog-2022/blogs/youtube.png?width=36&height=36&name=youtube.png) ](https://www.youtube.com/user/bccresearch) ![money back guarantee](https://blog.bccresearch.com/hs-fs/hubfs/bcc_blog-2022/blogs/money-back.png?width=60&height=60&name=money-back.png) ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Amrita Kumari", "url" : "https://blog.bccresearch.com/author/amrita-kumari" }, "dateModified" : "2025-08-13T13:00:05.457Z", "datePublished" : "2025-08-13T13:00:00.000Z", "headline" : "Top 10 Companies Leading the Global IBS and IBD Therapeutics Market", "image" : [ "https://blog.bccresearch.com/hubfs/Rare%20Disease.jpg" ], "mainEntityOfPage" : { "@id" : "https://blog.bccresearch.com/top-10-companies-leading-the-global-ibs-and-ibd-therapeutics-market", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://blog.bccresearch.com/hubfs/Logos/BCC-Logo-PSD-REMOVED-WHITE-BCC.png" }, "name" : "BCC Research LLC" } } ```